UCSF HELEN DILLER FAMILY COMPREHENSIVE CANCER CENTER

Presentations
Persistence of AR signaling in small cell neuroendocrine prostate
cancer (SCNC) and intermediate atypical carcinoma (IAC): Results from
the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WCDT).
Authors*: Rahul Raj Aggarwal, Jack Youngren, Artem Sokolov, Jiaoti Huang, George V. Thomas,
Lawrence D. True, Adam Foye, Joshi J. Alumkal, Charles J. Ryan, Tomasz M. Beer, Christopher P. Evans,
Martin Gleave, Matthew Rettig, Joshua M. Stuart, Primo Lara, Theodore C. Goldstein, Li Zhang,
Robert Evan Reiter, Kim N. Chi, Eric Jay Small
Abstract #: 5045
Presentation Date/Time: Saturday, June 4: 1:00 - 4:30 PM
Location: Hall A, Poster Board #302
Poster Session: Genitourinary (Prostate) Cancer
Citation: J Clin Oncol 34, 2016 (suppl; abstr 5045)
Small Research Interests: The Stand Up To Cancer Dream Team led by Dr. Eric Small is exploring the
idea that resistance to hormonal therapy occurs as a result of the prostate cancer cells using common
cellular responses - what the Dream Team calls “adaptive pathways” - to escape the current prostate
cancer therapies. They believe that, by identifying these pathways and inhibiting them, they will be able to
overcome treatment resistance and profoundly improve the care of men affected by this fatal disease. This
team is a six institution consortium to include UC Los Angeles, UC Davis, UC Santa Cruz, University of
British Columbia, Oregon Health and Sciences University, with UCSF as the lead administrative site.
http://cancer.ucsf.edu/people/profiles/small_eric.3671
*UCSF authors in bold
24